nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0258	0.0588	CbGeAlD
Loxapine—HTR3A—cranial nerve—amyotrophic lateral sclerosis	0.0166	0.0379	CbGeAlD
Loxapine—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.016	0.0444	CcSEcCtD
Loxapine—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.0145	0.0402	CcSEcCtD
Loxapine—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.0145	0.0402	CcSEcCtD
Loxapine—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.0145	0.0402	CcSEcCtD
Loxapine—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.0145	0.0402	CcSEcCtD
Loxapine—HTR1B—cranial nerve—amyotrophic lateral sclerosis	0.014	0.0318	CbGeAlD
Loxapine—HTR1D—cranial nerve—amyotrophic lateral sclerosis	0.0135	0.0308	CbGeAlD
Loxapine—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.013	0.036	CcSEcCtD
Loxapine—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0345	CcSEcCtD
Loxapine—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.0115	0.032	CcSEcCtD
Loxapine—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.0112	0.031	CcSEcCtD
Loxapine—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0303	CcSEcCtD
Loxapine—HTR7—cranial nerve—amyotrophic lateral sclerosis	0.0108	0.0245	CbGeAlD
Loxapine—HTR7—pons—amyotrophic lateral sclerosis	0.0106	0.0243	CbGeAlD
Loxapine—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00902	0.025	CcSEcCtD
Loxapine—DRD1—nerve—amyotrophic lateral sclerosis	0.00883	0.0201	CbGeAlD
Loxapine—HTR3A—nerve—amyotrophic lateral sclerosis	0.00853	0.0194	CbGeAlD
Loxapine—HTR5A—nervous system—amyotrophic lateral sclerosis	0.00797	0.0182	CbGeAlD
Loxapine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00773	0.0215	CcSEcCtD
Loxapine—HTR5A—central nervous system—amyotrophic lateral sclerosis	0.00767	0.0175	CbGeAlD
Loxapine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00753	0.0209	CcSEcCtD
Loxapine—Clobazam—SLC6A1—amyotrophic lateral sclerosis	0.00749	0.688	CrCbGaD
Loxapine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00723	0.0201	CcSEcCtD
Loxapine—SLC6A3—nerve—amyotrophic lateral sclerosis	0.00709	0.0162	CbGeAlD
Loxapine—HTR7—peripheral nervous system—amyotrophic lateral sclerosis	0.00708	0.0161	CbGeAlD
Loxapine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00684	0.019	CcSEcCtD
Loxapine—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00671	0.0153	CbGeAlD
Loxapine—HTR2A—pons—amyotrophic lateral sclerosis	0.00663	0.0151	CbGeAlD
Loxapine—HTR1E—brainstem—amyotrophic lateral sclerosis	0.00649	0.0148	CbGeAlD
Loxapine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00625	0.0173	CcSEcCtD
Loxapine—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00623	0.0173	CcSEcCtD
Loxapine—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00619	0.0172	CcSEcCtD
Loxapine—HTR5A—brain—amyotrophic lateral sclerosis	0.00609	0.0139	CbGeAlD
Loxapine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00595	0.0165	CcSEcCtD
Loxapine—SLC6A2—nerve—amyotrophic lateral sclerosis	0.00572	0.0131	CbGeAlD
Loxapine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00569	0.0158	CcSEcCtD
Loxapine—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.00566	0.0129	CbGeAlD
Loxapine—HTR7—nerve—amyotrophic lateral sclerosis	0.00552	0.0126	CbGeAlD
Loxapine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00548	0.0152	CcSEcCtD
Loxapine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00545	0.0151	CcSEcCtD
Loxapine—SLC6A3—hindbrain—amyotrophic lateral sclerosis	0.00531	0.0121	CbGeAlD
Loxapine—DRD2—nerve—amyotrophic lateral sclerosis	0.00522	0.0119	CbGeAlD
Loxapine—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00519	0.0118	CbGeAlD
Loxapine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00497	0.0138	CcSEcCtD
Loxapine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00494	0.0137	CcSEcCtD
Loxapine—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.00487	0.0111	CbGeAlD
Loxapine—HTR2A—appendage—amyotrophic lateral sclerosis	0.00485	0.0111	CbGeAlD
Loxapine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00484	0.0134	CcSEcCtD
Loxapine—Tension—Riluzole—amyotrophic lateral sclerosis	0.00468	0.013	CcSEcCtD
Loxapine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00467	0.013	CcSEcCtD
Loxapine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00458	0.0127	CcSEcCtD
Loxapine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00447	0.0124	CcSEcCtD
Loxapine—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00441	0.0101	CbGeAlD
Loxapine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00438	0.0122	CcSEcCtD
Loxapine—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00432	0.00986	CbGeAlD
Loxapine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00428	0.0119	CcSEcCtD
Loxapine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00427	0.0118	CcSEcCtD
Loxapine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00419	0.0116	CcSEcCtD
Loxapine—Cough—Riluzole—amyotrophic lateral sclerosis	0.00416	0.0116	CcSEcCtD
Loxapine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00413	0.0115	CcSEcCtD
Loxapine—HTR7—hindbrain—amyotrophic lateral sclerosis	0.00413	0.00942	CbGeAlD
Loxapine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00412	0.0114	CcSEcCtD
Loxapine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00406	0.0113	CcSEcCtD
Loxapine—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00399	0.00909	CbGeAlD
Loxapine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00397	0.011	CcSEcCtD
Loxapine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00392	0.0109	CcSEcCtD
Loxapine—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00391	0.00891	CbGeAlD
Loxapine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00389	0.0108	CcSEcCtD
Loxapine—Shock—Riluzole—amyotrophic lateral sclerosis	0.00383	0.0106	CcSEcCtD
Loxapine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00382	0.0106	CcSEcCtD
Loxapine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00381	0.0106	CcSEcCtD
Loxapine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0038	0.0105	CcSEcCtD
Loxapine—DRD1—brainstem—amyotrophic lateral sclerosis	0.00379	0.00864	CbGeAlD
Loxapine—HTR3A—brainstem—amyotrophic lateral sclerosis	0.00366	0.00835	CbGeAlD
Loxapine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00364	0.0101	CcSEcCtD
Loxapine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00352	0.00977	CcSEcCtD
Loxapine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00349	0.0097	CcSEcCtD
Loxapine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00963	CcSEcCtD
Loxapine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00346	0.0096	CcSEcCtD
Loxapine—HTR2A—nerve—amyotrophic lateral sclerosis	0.00344	0.00785	CbGeAlD
Loxapine—HTR1E—nervous system—amyotrophic lateral sclerosis	0.0034	0.00776	CbGeAlD
Loxapine—Trifluoperazine—SIGMAR1—amyotrophic lateral sclerosis	0.00339	0.312	CrCbGaD
Loxapine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00933	CcSEcCtD
Loxapine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00931	CcSEcCtD
Loxapine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00924	CcSEcCtD
Loxapine—HTR1E—central nervous system—amyotrophic lateral sclerosis	0.00327	0.00747	CbGeAlD
Loxapine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00321	0.0089	CcSEcCtD
Loxapine—HTR1B—brainstem—amyotrophic lateral sclerosis	0.00307	0.007	CbGeAlD
Loxapine—SLC6A3—brainstem—amyotrophic lateral sclerosis	0.00305	0.00695	CbGeAlD
Loxapine—DRD4—brain—amyotrophic lateral sclerosis	0.00301	0.00688	CbGeAlD
Loxapine—CHRM4—nervous system—amyotrophic lateral sclerosis	0.00298	0.0068	CbGeAlD
Loxapine—HTR1D—brainstem—amyotrophic lateral sclerosis	0.00297	0.00678	CbGeAlD
Loxapine—HTR2C—brainstem—amyotrophic lateral sclerosis	0.00294	0.00671	CbGeAlD
Loxapine—CHRM4—central nervous system—amyotrophic lateral sclerosis	0.00287	0.00655	CbGeAlD
Loxapine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00796	CcSEcCtD
Loxapine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00279	0.00775	CcSEcCtD
Loxapine—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.00279	0.00636	CbGeAlD
Loxapine—DRD3—nervous system—amyotrophic lateral sclerosis	0.00277	0.00632	CbGeAlD
Loxapine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00764	CcSEcCtD
Loxapine—DRD3—central nervous system—amyotrophic lateral sclerosis	0.00267	0.00609	CbGeAlD
Loxapine—HTR6—nervous system—amyotrophic lateral sclerosis	0.00267	0.00609	CbGeAlD
Loxapine—HTR1E—brain—amyotrophic lateral sclerosis	0.0026	0.00593	CbGeAlD
Loxapine—DRD5—nervous system—amyotrophic lateral sclerosis	0.0026	0.00593	CbGeAlD
Loxapine—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00258	0.00588	CbGeAlD
Loxapine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00257	0.00714	CcSEcCtD
Loxapine—HTR6—central nervous system—amyotrophic lateral sclerosis	0.00257	0.00586	CbGeAlD
Loxapine—DRD5—central nervous system—amyotrophic lateral sclerosis	0.0025	0.00571	CbGeAlD
Loxapine—HTR1A—brainstem—amyotrophic lateral sclerosis	0.00248	0.00565	CbGeAlD
Loxapine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00247	0.00687	CcSEcCtD
Loxapine—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.00246	0.0056	CbGeAlD
Loxapine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00681	CcSEcCtD
Loxapine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00681	CcSEcCtD
Loxapine—HRH2—nervous system—amyotrophic lateral sclerosis	0.00244	0.00557	CbGeAlD
Loxapine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00677	CcSEcCtD
Loxapine—HTR7—brainstem—amyotrophic lateral sclerosis	0.00237	0.0054	CbGeAlD
Loxapine—HRH2—central nervous system—amyotrophic lateral sclerosis	0.00235	0.00536	CbGeAlD
Loxapine—CHRM5—nervous system—amyotrophic lateral sclerosis	0.00233	0.00532	CbGeAlD
Loxapine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00642	CcSEcCtD
Loxapine—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.00228	0.00521	CbGeAlD
Loxapine—CHRM4—brain—amyotrophic lateral sclerosis	0.00228	0.0052	CbGeAlD
Loxapine—CHRM5—central nervous system—amyotrophic lateral sclerosis	0.00224	0.00512	CbGeAlD
Loxapine—DRD2—brainstem—amyotrophic lateral sclerosis	0.00224	0.00511	CbGeAlD
Loxapine—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00213	0.00486	CbGeAlD
Loxapine—DRD3—brain—amyotrophic lateral sclerosis	0.00212	0.00483	CbGeAlD
Loxapine—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00205	0.00468	CbGeAlD
Loxapine—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.00205	0.00468	CbGeAlD
Loxapine—HTR6—brain—amyotrophic lateral sclerosis	0.00204	0.00465	CbGeAlD
Loxapine—DRD5—brain—amyotrophic lateral sclerosis	0.00199	0.00453	CbGeAlD
Loxapine—DRD1—nervous system—amyotrophic lateral sclerosis	0.00199	0.00453	CbGeAlD
Loxapine—HTR3A—nervous system—amyotrophic lateral sclerosis	0.00192	0.00437	CbGeAlD
Loxapine—DRD1—central nervous system—amyotrophic lateral sclerosis	0.00191	0.00436	CbGeAlD
Loxapine—HTR1B—spinal cord—amyotrophic lateral sclerosis	0.00191	0.00435	CbGeAlD
Loxapine—SLC6A3—spinal cord—amyotrophic lateral sclerosis	0.00189	0.00432	CbGeAlD
Loxapine—HRH2—brain—amyotrophic lateral sclerosis	0.00187	0.00425	CbGeAlD
Loxapine—HTR3A—central nervous system—amyotrophic lateral sclerosis	0.00185	0.00421	CbGeAlD
Loxapine—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00183	0.00417	CbGeAlD
Loxapine—CHRM5—brain—amyotrophic lateral sclerosis	0.00178	0.00406	CbGeAlD
Loxapine—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.00174	0.00396	CbGeAlD
Loxapine—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.00171	0.00391	CbGeAlD
Loxapine—HTR7—medulla oblongata—amyotrophic lateral sclerosis	0.00165	0.00377	CbGeAlD
Loxapine—ADRA1B—brain—amyotrophic lateral sclerosis	0.00163	0.00371	CbGeAlD
Loxapine—HTR2A—embryo—amyotrophic lateral sclerosis	0.00161	0.00368	CbGeAlD
Loxapine—HTR1B—nervous system—amyotrophic lateral sclerosis	0.00161	0.00367	CbGeAlD
Loxapine—CHRM2—nervous system—amyotrophic lateral sclerosis	0.0016	0.00365	CbGeAlD
Loxapine—SLC6A3—nervous system—amyotrophic lateral sclerosis	0.0016	0.00364	CbGeAlD
Loxapine—HTR1D—nervous system—amyotrophic lateral sclerosis	0.00156	0.00355	CbGeAlD
Loxapine—HTR1B—central nervous system—amyotrophic lateral sclerosis	0.00155	0.00353	CbGeAlD
Loxapine—HTR2C—nervous system—amyotrophic lateral sclerosis	0.00154	0.00352	CbGeAlD
Loxapine—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.00154	0.00351	CbGeAlD
Loxapine—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.00154	0.00351	CbGeAlD
Loxapine—SLC6A3—central nervous system—amyotrophic lateral sclerosis	0.00154	0.0035	CbGeAlD
Loxapine—ADRA2C—medulla oblongata—amyotrophic lateral sclerosis	0.00152	0.00346	CbGeAlD
Loxapine—DRD1—brain—amyotrophic lateral sclerosis	0.00152	0.00346	CbGeAlD
Loxapine—ADRB1—nervous system—amyotrophic lateral sclerosis	0.00151	0.00345	CbGeAlD
Loxapine—SLC6A3—cerebellum—amyotrophic lateral sclerosis	0.0015	0.00342	CbGeAlD
Loxapine—HTR1D—central nervous system—amyotrophic lateral sclerosis	0.0015	0.00342	CbGeAlD
Loxapine—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.00148	0.00339	CbGeAlD
Loxapine—HTR2A—brainstem—amyotrophic lateral sclerosis	0.00148	0.00337	CbGeAlD
Loxapine—HTR7—spinal cord—amyotrophic lateral sclerosis	0.00147	0.00336	CbGeAlD
Loxapine—HTR3A—brain—amyotrophic lateral sclerosis	0.00147	0.00334	CbGeAlD
Loxapine—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.00146	0.00333	CbGeAlD
Loxapine—ADRB1—central nervous system—amyotrophic lateral sclerosis	0.00146	0.00332	CbGeAlD
Loxapine—CHRM1—nervous system—amyotrophic lateral sclerosis	0.00146	0.00332	CbGeAlD
Loxapine—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.00141	0.00321	CbGeAlD
Loxapine—CHRM1—central nervous system—amyotrophic lateral sclerosis	0.0014	0.0032	CbGeAlD
Loxapine—ADRA2C—spinal cord—amyotrophic lateral sclerosis	0.00135	0.00309	CbGeAlD
Loxapine—CHRM3—nervous system—amyotrophic lateral sclerosis	0.0013	0.00297	CbGeAlD
Loxapine—HTR1A—nervous system—amyotrophic lateral sclerosis	0.0013	0.00296	CbGeAlD
Loxapine—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.00129	0.00294	CbGeAlD
Loxapine—CHRM3—central nervous system—amyotrophic lateral sclerosis	0.00125	0.00286	CbGeAlD
Loxapine—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.00125	0.00285	CbGeAlD
Loxapine—HTR7—nervous system—amyotrophic lateral sclerosis	0.00124	0.00283	CbGeAlD
Loxapine—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.00124	0.00283	CbGeAlD
Loxapine—HTR1B—brain—amyotrophic lateral sclerosis	0.00123	0.0028	CbGeAlD
Loxapine—CHRM2—brain—amyotrophic lateral sclerosis	0.00122	0.00279	CbGeAlD
Loxapine—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.00122	0.00279	CbGeAlD
Loxapine—SLC6A3—brain—amyotrophic lateral sclerosis	0.00122	0.00278	CbGeAlD
Loxapine—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00121	0.00276	CbGeAlD
Loxapine—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.0012	0.00273	CbGeAlD
Loxapine—HTR7—central nervous system—amyotrophic lateral sclerosis	0.00119	0.00272	CbGeAlD
Loxapine—HTR1D—brain—amyotrophic lateral sclerosis	0.00119	0.00272	CbGeAlD
Loxapine—HTR2C—brain—amyotrophic lateral sclerosis	0.00118	0.00269	CbGeAlD
Loxapine—DRD2—nervous system—amyotrophic lateral sclerosis	0.00117	0.00268	CbGeAlD
Loxapine—HTR7—cerebellum—amyotrophic lateral sclerosis	0.00117	0.00266	CbGeAlD
Loxapine—ADRB1—brain—amyotrophic lateral sclerosis	0.00116	0.00264	CbGeAlD
Loxapine—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.00115	0.00263	CbGeAlD
Loxapine—ADRA2C—nervous system—amyotrophic lateral sclerosis	0.00114	0.0026	CbGeAlD
Loxapine—DRD2—central nervous system—amyotrophic lateral sclerosis	0.00113	0.00258	CbGeAlD
Loxapine—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.00113	0.00257	CbGeAlD
Loxapine—SLC6A4—brain—amyotrophic lateral sclerosis	0.00112	0.00255	CbGeAlD
Loxapine—CHRM1—brain—amyotrophic lateral sclerosis	0.00111	0.00254	CbGeAlD
Loxapine—DRD2—cerebellum—amyotrophic lateral sclerosis	0.0011	0.00252	CbGeAlD
Loxapine—ADRA2C—central nervous system—amyotrophic lateral sclerosis	0.0011	0.0025	CbGeAlD
Loxapine—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.00108	0.00246	CbGeAlD
Loxapine—ADRA2C—cerebellum—amyotrophic lateral sclerosis	0.00107	0.00245	CbGeAlD
Loxapine—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.00103	0.00235	CbGeAlD
Loxapine—CHRM3—brain—amyotrophic lateral sclerosis	0.000996	0.00227	CbGeAlD
Loxapine—HTR1A—brain—amyotrophic lateral sclerosis	0.000992	0.00226	CbGeAlD
Loxapine—SLC6A2—brain—amyotrophic lateral sclerosis	0.000984	0.00224	CbGeAlD
Loxapine—HTR7—brain—amyotrophic lateral sclerosis	0.000948	0.00216	CbGeAlD
Loxapine—HRH1—nervous system—amyotrophic lateral sclerosis	0.000926	0.00211	CbGeAlD
Loxapine—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.000918	0.00209	CbGeAlD
Loxapine—ADRA1A—brain—amyotrophic lateral sclerosis	0.000915	0.00209	CbGeAlD
Loxapine—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.00091	0.00208	CbGeAlD
Loxapine—DRD2—brain—amyotrophic lateral sclerosis	0.000897	0.00204	CbGeAlD
Loxapine—HRH1—central nervous system—amyotrophic lateral sclerosis	0.000892	0.00203	CbGeAlD
Loxapine—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.000876	0.002	CbGeAlD
Loxapine—ADRA2C—brain—amyotrophic lateral sclerosis	0.000872	0.00199	CbGeAlD
Loxapine—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.000856	0.00195	CbGeAlD
Loxapine—HTR2A—nervous system—amyotrophic lateral sclerosis	0.000774	0.00176	CbGeAlD
Loxapine—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.000745	0.0017	CbGeAlD
Loxapine—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.000728	0.00166	CbGeAlD
Loxapine—HRH1—brain—amyotrophic lateral sclerosis	0.000708	0.00161	CbGeAlD
Loxapine—ADRA2A—brain—amyotrophic lateral sclerosis	0.000695	0.00159	CbGeAlD
Loxapine—HTR2A—brain—amyotrophic lateral sclerosis	0.000591	0.00135	CbGeAlD
Loxapine—ADRA2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.74e-05	0.000196	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.74e-05	0.000196	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.73e-05	0.000196	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.72e-05	0.000196	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.72e-05	0.000195	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.71e-05	0.000195	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.71e-05	0.000195	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.7e-05	0.000195	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.7e-05	0.000194	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.69e-05	0.000194	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.68e-05	0.000193	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.68e-05	0.000193	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.67e-05	0.000193	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.66e-05	0.000192	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.65e-05	0.000192	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.61e-05	0.00019	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.61e-05	0.000189	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.6e-05	0.000189	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.57e-05	0.000187	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.56e-05	0.000187	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.55e-05	0.000186	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.5e-05	0.000184	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.5e-05	0.000184	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.5e-05	0.000184	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.49e-05	0.000183	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.48e-05	0.000183	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.47e-05	0.000182	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.46e-05	0.000182	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.46e-05	0.000182	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.45e-05	0.000181	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.45e-05	0.000181	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.44e-05	0.000181	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.43e-05	0.00018	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.43e-05	0.00018	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.42e-05	0.00018	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.4e-05	0.000179	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.39e-05	0.000178	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.36e-05	0.000176	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.35e-05	0.000176	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.34e-05	0.000175	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.33e-05	0.000175	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.32e-05	0.000174	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.31e-05	0.000174	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.31e-05	0.000174	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.3e-05	0.000174	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.29e-05	0.000173	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.28e-05	0.000172	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.27e-05	0.000172	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.26e-05	0.000171	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.25e-05	0.000171	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.22e-05	0.000169	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.22e-05	0.000169	CbGpPWpGaD
Loxapine—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	3.2e-05	0.000168	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.2e-05	0.000168	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.19e-05	0.000168	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.19e-05	0.000167	CbGpPWpGaD
Loxapine—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	3.19e-05	0.000167	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.18e-05	0.000167	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.18e-05	0.000167	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.15e-05	0.000166	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.15e-05	0.000165	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.14e-05	0.000165	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.12e-05	0.000164	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.11e-05	0.000163	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.09e-05	0.000162	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.04e-05	0.00016	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.04e-05	0.000159	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.01e-05	0.000158	CbGpPWpGaD
Loxapine—ADRA2C—Hemostasis—TP53—amyotrophic lateral sclerosis	2.98e-05	0.000156	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.97e-05	0.000156	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.96e-05	0.000155	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—APOE—amyotrophic lateral sclerosis	2.96e-05	0.000155	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.93e-05	0.000154	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.92e-05	0.000153	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.9e-05	0.000152	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.87e-05	0.000151	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.86e-05	0.00015	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.86e-05	0.00015	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.85e-05	0.00015	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.85e-05	0.00015	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.85e-05	0.00015	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.85e-05	0.00015	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.85e-05	0.000149	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.84e-05	0.000149	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.83e-05	0.000149	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.83e-05	0.000149	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.8e-05	0.000147	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.8e-05	0.000147	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.77e-05	0.000146	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.75e-05	0.000144	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.73e-05	0.000144	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.73e-05	0.000143	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.73e-05	0.000143	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.73e-05	0.000143	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.71e-05	0.000142	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.69e-05	0.000141	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.69e-05	0.000141	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.69e-05	0.000141	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.68e-05	0.000141	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.67e-05	0.00014	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.67e-05	0.00014	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.66e-05	0.00014	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.66e-05	0.00014	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.65e-05	0.000139	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.64e-05	0.000138	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.63e-05	0.000138	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—APOE—amyotrophic lateral sclerosis	2.62e-05	0.000138	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.62e-05	0.000137	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.6e-05	0.000136	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.58e-05	0.000135	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.56e-05	0.000134	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.54e-05	0.000134	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.47e-05	0.00013	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.46e-05	0.000129	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.44e-05	0.000128	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.44e-05	0.000128	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.43e-05	0.000128	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.42e-05	0.000127	CbGpPWpGaD
Loxapine—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	2.42e-05	0.000127	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.42e-05	0.000127	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.41e-05	0.000127	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	2.4e-05	0.000126	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.37e-05	0.000125	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.37e-05	0.000124	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.37e-05	0.000124	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.36e-05	0.000124	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.35e-05	0.000124	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.33e-05	0.000122	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.32e-05	0.000122	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.25e-05	0.000118	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.21e-05	0.000116	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.21e-05	0.000116	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.2e-05	0.000116	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.2e-05	0.000115	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.2e-05	0.000115	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.19e-05	0.000115	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.19e-05	0.000115	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.19e-05	0.000115	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.18e-05	0.000115	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.17e-05	0.000114	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.16e-05	0.000114	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.16e-05	0.000113	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.14e-05	0.000112	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.11e-05	0.000111	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.1e-05	0.00011	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.1e-05	0.00011	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.08e-05	0.000109	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.07e-05	0.000109	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.07e-05	0.000109	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.06e-05	0.000108	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.06e-05	0.000108	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.04e-05	0.000107	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.03e-05	0.000107	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.02e-05	0.000106	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.01e-05	0.000106	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.01e-05	0.000106	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.99e-05	0.000104	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.99e-05	0.000104	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.96e-05	0.000103	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.89e-05	9.94e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.88e-05	9.85e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.87e-05	9.8e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.86e-05	9.79e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.86e-05	9.78e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.86e-05	9.75e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.85e-05	9.72e-05	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.84e-05	9.65e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.83e-05	9.59e-05	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.83e-05	9.59e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.82e-05	9.57e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.82e-05	9.54e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.81e-05	9.52e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.81e-05	9.51e-05	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.79e-05	9.43e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.79e-05	9.42e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.79e-05	9.39e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.79e-05	9.39e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.78e-05	9.37e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.76e-05	9.26e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.76e-05	9.24e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.7e-05	8.93e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.68e-05	8.85e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.68e-05	8.85e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.66e-05	8.72e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.65e-05	8.65e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.63e-05	8.54e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.62e-05	8.5e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.61e-05	8.44e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.61e-05	8.43e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.59e-05	8.36e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.58e-05	8.32e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.57e-05	8.27e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.55e-05	8.14e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.54e-05	8.07e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.53e-05	8.03e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.49e-05	7.81e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.46e-05	7.69e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.44e-05	7.58e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.43e-05	7.51e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.43e-05	7.5e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.41e-05	7.4e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.41e-05	7.39e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.41e-05	7.38e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.4e-05	7.37e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.4e-05	7.34e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.4e-05	7.34e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.39e-05	7.32e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.38e-05	7.25e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.38e-05	7.25e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.38e-05	7.23e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.37e-05	7.21e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.37e-05	7.19e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.35e-05	7.09e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.35e-05	7.08e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.34e-05	7.02e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.33e-05	6.98e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.33e-05	6.98e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.33e-05	6.96e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.32e-05	6.94e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.32e-05	6.92e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.31e-05	6.9e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.3e-05	6.85e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.3e-05	6.83e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.28e-05	6.72e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.27e-05	6.69e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.21e-05	6.37e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.21e-05	6.37e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.21e-05	6.35e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.2e-05	6.29e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.19e-05	6.26e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.19e-05	6.25e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.19e-05	6.23e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.18e-05	6.21e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.17e-05	6.15e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.17e-05	6.13e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.09e-05	5.73e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.08e-05	5.7e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.08e-05	5.67e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.04e-05	5.48e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.04e-05	5.45e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.01e-05	5.3e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.93e-06	5.22e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.16e-06	4.81e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.01e-06	4.73e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.99e-06	4.72e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.96e-06	4.71e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.93e-06	4.69e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.85e-06	4.65e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.82e-06	4.63e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.2e-06	4.31e-05	CbGpPWpGaD
